Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulia Ron

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Gastroenterology|October 16, 2020
Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel DiseaseEinat Ritter, Ayal Hirsch, Naomi F Isakov, et al.
World Journal of Gastroenterology|March 14, 2013
Ensure preparation and capsule endoscopy: a two-center prospective studyEva Niv, Baruch Ovadia, Yulia Ron, et al.
International Journal of Colorectal Disease|January 6, 2021
A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotypeSharif Yassin, Naomi Fliss Isakov, Yulia Ron, et al.
Journal of Digestive Diseases|October 10, 2025
Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic-Experienced Patients With Ulcerative Colitis: A Retrospective StudyNeta Sror, Haim Leibovitzh, Ayal Hirsch, et al.
European Journal of Clinical Nutrition|April 24, 2020
Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patientsChen Sarbagili-Shabat, Shira Zelber-Sagi, Naomi Fliss Isakov, et al.
Inflammatory Bowel Diseases|October 31, 2014
Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic studyIris Dotan, Yulia Ron, Henit Yanai, et al.
European Journal of Gastroenterology & Hepatology|February 24, 2017
Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skillsAnat Yerushalmy-Feler, Yulia Ron, Efrat Barnea, et al.
Digestion|August 30, 2017
Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic StrategiesOded Icht, Henit Yanai, Yulia Ron, et al.
Scandinavian Journal of Gastroenterology|June 3, 2026
Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatmentsTom Borkovsky, Nathaniel Aviv Cohen, Ori Shoam, et al.
Journal of Clinical Medicine|August 26, 2023
Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease: Real-World Experience from a Tertiary CenterNaomi Fliss-Isakov, Nathaniel Aviv Cohen, Ahuva Bromberg, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Gastroenterology|October 16, 2020
Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel DiseaseEinat Ritter, Ayal Hirsch, Naomi F Isakov, et al.
World Journal of Gastroenterology|March 14, 2013
Ensure preparation and capsule endoscopy: a two-center prospective studyEva Niv, Baruch Ovadia, Yulia Ron, et al.
International Journal of Colorectal Disease|January 6, 2021
A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotypeSharif Yassin, Naomi Fliss Isakov, Yulia Ron, et al.
Journal of Digestive Diseases|October 10, 2025
Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic-Experienced Patients With Ulcerative Colitis: A Retrospective StudyNeta Sror, Haim Leibovitzh, Ayal Hirsch, et al.
European Journal of Clinical Nutrition|April 24, 2020
Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patientsChen Sarbagili-Shabat, Shira Zelber-Sagi, Naomi Fliss Isakov, et al.
Inflammatory Bowel Diseases|October 31, 2014
Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic studyIris Dotan, Yulia Ron, Henit Yanai, et al.
European Journal of Gastroenterology & Hepatology|February 24, 2017
Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skillsAnat Yerushalmy-Feler, Yulia Ron, Efrat Barnea, et al.
Digestion|August 30, 2017
Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic StrategiesOded Icht, Henit Yanai, Yulia Ron, et al.
Scandinavian Journal of Gastroenterology|June 3, 2026
Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatmentsTom Borkovsky, Nathaniel Aviv Cohen, Ori Shoam, et al.
Journal of Clinical Medicine|August 26, 2023
Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease: Real-World Experience from a Tertiary CenterNaomi Fliss-Isakov, Nathaniel Aviv Cohen, Ahuva Bromberg, et al.
Pageof 5